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Abstract
Introduction: Treatment of elderly patients is in many ways different from that for younger ones. The aim of the
present study was to identify the particular characteristics and needs of elderly patients suffering from head and
neck cancer. From these patterns, considerations for this special group can be deduced.
Patients and Material: The subjects for this study consisted of 376 patients suffering from head and neck cancer
that were treated between 1999 and 2008, 99 (26.3.%) of whom were older than 70 years and were evaluated
retrospectively concerning smoking/alcohol abuse, ASA status, kind of malignant neoplasm, localization and
treatment.
Results: The male-female ratio was 53:46, and mean age, 79 years (71 - 98). Out of 95 patients with a squamous
cell carcinoma, 4 patients had a verrucous form. Out of 99 patients, 26 had a maxillary carcinoma and 12 patients
had experienced previous non-head-and-neck cancer. An ASA score of 2 or 3 was found in 86 of the patients.
Conclusion: The group of patients with head and neck cancer who were older than 70 years was characterized by
a higher portion of female patients, a higher number of maxillary carcinomas, and a higher prevalence of previous
second cancer.
Making decisions in cancer therapy for elderly patients is challenging. Patients suffering from operable head and
neck cancer should be treated with curative intent and with regard to quality of life if a careful assessment of
comorbidities is performed preoperatively.
Introduction
The percentage of elderly people with head and neck
cancer is rising due to an overall increase in life expec-
tancy. Age has been shown to be an independent pre-
dictor of perioperative outcome, morbidity, and
mortality risk. The main risk factors for head and neck
cancer can be smoking and alcohol consumption, and
these factors are also often associated with cardiovascu-
lar and pulmonary comorbidities, leading to a challenge
concerning treatment decisions in this patient group.
An aging heart has less efficient cardiac output under
the stress of surgery and anaesthesia, leading to lower
renal blood flow and possibly causing a higher sensibility
for greater water and electrolyte imbalances. Further-
more, pulmonary function is compromised with
increased age due to smaller vital capacities and poorer
gas exchange because of deterioration of the lung par-
enchyma (Table 1).
In the literature, no exact age seems to be associated
with the word “elderly.” In any case, surgical indications
should not be based on age, but rather on risk assess-
ment. Socinski et al. defined an “old patient” as one
whose health status has begun to interfere with oncolo-
gical decision-making guidelines [1]. Therefore, some
authors recommend using the ASA score as a tool for
risk assessment [2-4].
Postoperative delirium is a common complication, with
the overall incidence estimated at 10% in elderly patients
following major elective non-cardiac surgery [7]. It
usually presents around 24 hours postoperatively, resol-
ving in most patients within 48 hours, but episodes can
last for months [8]. With delirium the course usually
fluctuates and revolves over some days, up to a week, but
with dementia symptoms are progressive. Hallucinations
and delusions are also often absent in dementia, unlike in
delirium. Concerning therapy, Dexmedetomidine is
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recommended for long-term sedation in the intensive
care unit (ICU) as it leads to a decreased incidence of
ICU delirium [9,10], while low-dose Haloperidol or
Donazepil does not reduce the incidence [11-13].
In general, preoperative risk assessment is predictive
for the development of postoperative morbidity [14-16].
Serletti et al. [2] regarded surgical time longer than
10 hours as a predictive factor for development of post-
operative surgical complications. Further factors are
large fluid shifts and significant blood loss. Another
important factor in reconstructive failure seems to be
the presence of peripheral vascular disease.
Concerning chemotherapy, Shayne et al. reported that
in patients ≥ 70 years who were receiving full-dose che-
motherapy, increasing age alone did not increase the
risk of hematologic toxicity [17].
The aim of the present study is to identify the con-
cerns and needs of elderly patients suffering from head
and neck cancer. From these patterns special considera-
tions for this group can be deduced.
Patients and Material
Out of 376 patients treated from 1999 through 2008
that were suffering from head and neck cancer, 99
(26.3%) were older than 70 years. This group was evalu-
ated retrospectively concerning smoking/alcohol abuse,
ASA status, kind of malignant neoplasm, location of
malignancy, treatment, and outcome.
Results
Gender distribution, smoking, alcohol
The male-female ratio was 46:53, the mean age 79 years
(71 - 98) (Figure 1). Out of 90 evaluated patients, 20
Table 1 Age-related changes according to Priebe and
Lakatta [5,6].
Influence Age-related change
Organ
function
Respiratory - Increased chest wall rigidity
- Decreased functional alveolar surface
area, decreased gas exchange
- Decreased respiratory muscle strength
and endurance
Hepatic - Decreased activity of hepatic
cholinesterase
- Decrease in microsomal demethylation
pathway
Renal - Reduced glomerular filtration rate
- Decreased renal blood flow
- Reduction in total body water
Miscellaneous - Reduced skeletal mass
- Reduced cortisol secretion
Cardiac - Increased myocardial stiffness
- Increased aortic impedance
- Increased left atrium size
Vascular - Increased vascular stiffness
- Decreased b-adrenoceptor
responsiveness
Drug
Disposition
Drug
distribution
- Reduced total body water
- Reduced body mass
- Reduced serum albumin
Renal
excretion
- Reduced glomerular filtration rate
- Reduced renal blood flow
- Reduced concentrating ability
Hepatic
metabolism
- Reduced hepatic blood flow
- Reduced activity of microsomal
oxidizing system
Figure 1 Age distribution of all patients over 70 years.
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were still smoking (Figure 2), and 51 out of 77 patients
said they did not consume alcohol (Figure 3).
Kind of malignant neoplasm, location
Out of 95 patients with a squamous cell carcinoma, 4
had a verrucous form. The male-to-female distribution
of those patients with a verrucous form was 1:3; none of
them developed lymph node metastases or recurrence.
Five patients revealed a malignoma of the small salivary
glands, 2 patients a malignant melanoma, and one a
metastasis of a prostate carcinoma. The different loca-
tions of malignant neoplasms are presented in Figure 4.
Almost one-third was localized in the maxilla, and the
second most common location was the mandible ridge,
followed by the tongue.
ASA status, general diseases
Concerning assessment of personal surgery risk, the
ASA status was determined as listed in Figure 5. Out of
92 evaluated patients with an ASA score, 86 were either
ASA class II or class III.
Most of the patients had some type of cardiovascular
disease, and in 12 patients a previous non-head-and-
neck cancer was found (Figure 6).
The different therapies are listed in Figure 7. The
most common therapy was primary closure followed by
obturator prosthesis. Concerning the outcome (Figure
8), 44 patients were recurrence free, but the median fol-
low-up time was 25.5 months because a large portion of
the elderly patients did not appear at their follow-up
sessions.
Discussion
Muir et al. estimated that as many as 24% of head and
neck cancers are found in patients older than 70 years
[18], and this was supported by our study. A higher
female proportion, as in the present study, was also con-
firmed by Sarini et al. [19].
Figure 2 Risk factor smoking.
Figure 3 Risk factor alcohol.
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mouth floor; 8
tongue; 18
mandible alveolar 
ridge; 23
maxilla alveolar 
ridge; 23
hard palate; 3
soft palate; 2
buccal; 4
lower lip; 4
upper lip; 2
other; 12
mouth floor
tongue
mandible alveolar ridge
maxilla alveolar ridge
hard palate
soft palate
buccal
lower lip
upper lip
other
Figure 4 Location of tumors.
Figure 5 ASA status of all patients.
Figure 6 Distribution of general diseases (DM = Diabetes mellitus).
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Furthermore, in the present study the rate of patients
with alcohol abuse or smoking risk factors was found to
be lower than that in younger patient groups. This find-
ing follows the logic that malignant tumors occur earlier
under the influence of risk factors, but are also likely to
occur without them as time passes by. Malignancy may
interfere with accumulation of mutations, decreased effi-
ciency in DNA repair, and reduced immune surveillance.
Concerning the higher portion of maxillary carcino-
mas in elderly patients, similar results can be shown in
other studies [20,21]. These findings are also important
with regard to therapy planning because performing
elective neck dissections for maxillary carcinoma is still
controversial. It is also striking that, particularly in max-
illary carcinoma, the proportion of females is higher
than that of males [21].
Figure 7 Treatment of elderly patients.
Figure 8 Outcome.
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Four patients had a verrucous form; this type of well-
differentiated squamous cell carcinoma is well known in
elderly patients [22].
In deciding which treatment strategy would be suita-
ble for an individual elderly patient, a comprehensive
geriatric assessment seems to be the essential step,
because age by itself is an unreliable parameter for deci-
sion making. In the present study, only 3 patients had
an ASA status of 1, and the predominant therapy was
primary closure.
Due to changed renal function (reduced glomerular
filtration rate, decreased renal blood flow) and changed
hepatic metabolism (reduced hepatic blood flow and
reduced activity of the microsomal oxidizing system),
drug distribution is also changed in elderly patients.
Moreover, increased myocardial stiffness, increased aor-
tic impedance, increased left atrium size, and increased
vascular stiffness, in addition to decreased b-adrenocep-
tor responsiveness, must be considered before a surgical
treatment is planned for elderly patients (Table 1).
Though our population is becoming older and, there-
fore, the risk of developing cancer is also increasing, lit-
tle research evaluating age-related toxicities has been
conducted, and age-related guidelines for chemotherapy
administration are often missing. The therapy decision
should be based on the patient’s wishes, ASA score, and
combined quality of life and function, instead of being
based on the patient’s age and years of life expectancy.
Perioperative mortality
In 810 patients older than 65 years who had undergone
major head and neck resections under general anaesthesia,
Morgan et al. reported a mortality rate as low as 3.5% [23].
In addition, Jones et al. reported no significant differences
in perioperative or postoperative complications between
head and neck cancer patients older than 70 years and
patients younger than 66 years, although the older group
had a higher frequency of morbid preoperative conditions
[24]. In the present study the ASA score was applied preo-
peratively in order to evaluate the individual surgical risk,
and none of the patients died perioperatively.
Microvascular
Controversy still surrounds microvascular free tissue
transfer. Studies dealing with free tissue in the elderly
have been done for those aged 50 years [3,25], 60 years
[14], 65 years[2,15], and 70 years [16]. The flap loss rate
in these studies ranged from 1% out of 92 patients [25]
to 16.7% out of 47 patients [14,24].
Blackwell et al. reported that microvascular reconstruc-
tions in elderly patients are reliable, but the incidence of
medical complications and costs has significantly increased
[25]. The success rate of free flaps seems no different from
that for other age groups, but postoperative medical
complications seem to be directly related to the presence
of concurrent illness [3]. In the current study a microvas-
cular reconstruction was performed in only 13 patients; in
all cases it was for mandible/mouth floor or tongue recon-
struction. For maxilla, the most common closure was per-
formed by an obturator prosthesis, followed by primary
closure or temporal/nasolabial flaps.
Conclusion
Even if the concept of “elderly” has no clearly defined
parameters, these patients do have a different pattern of
head and neck tumors with regard to risk factors, tumor
entities, and treatment options. The group of patients
older than 70 years with head and neck cancer is char-
acterized by a higher proportion of female patients, a
higher number of maxillary carcinomas, and a higher
prevalence of previous cancers.
Therefore the elderly patient does require an exact
evaluation of his biological situation and an especially
individual treatment concept.
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